ArticleJournal of gastrointestinal oncology2011
FDG PET imaging in the staging and management of gastric cancer.
Article in Journal of gastrointestinal oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Survival outcomes in patients with stages I-III gastric adenocarcinoma treated with surgery alone versus surgery plus adjuvant chemotherapy: A systematic review.Journal of biological methods · 2025Review
- Use of 18-Fluorodeoxyglucose Positron Emission Tomography and Near-Infrared Fluorescence-Guided Imaging Surgery in the Treatment of a Gastric Tumor in a Dog.Animals : an open access journal from MDPI · 2024Article
- Article
- Pleural Effusion as the Initial Presentation of Gastric Adenocarcinoma: A Case Report.The American journal of case reports · 2022Article
- Risk factors for lymph node metastasis in early gastric cancer patients: Report from Eastern Europe country- Lithuania.BMC surgery · 2017Article
- Article
- The utility of positron emission tomography/computed tomography in target delineation for stereotactic body radiotherapy for liver metastasis from primary gastric cancer: an illustrative case report and literature review.Journal of gastrointestinal oncology · 2017Article
- Noninvasive detection of gastric cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016Review
- Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.World journal of gastroenterology · 2015Article
- Rab40b upregulation correlates with the prognosis of gastric cancer by promoting migration, invasion, and metastasis.Medical oncology (Northwood, London, England) · 2015Article
- Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.Therapeutics and clinical risk management · 2015Review
- Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.American journal of cancer research · 2015Article
- New approaches to gastric cancer staging: beyond endoscopic ultrasound, computed tomography and positron emission tomography.World journal of gastroenterology · 2014Review
- Article
- Expression of Rab25 correlates with the invasion and metastasis of gastric cancer.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2013Article
- Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013Article
- RKIP expression associated with gastric cancer cell invasion and metastasis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012Article
- Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma.Molecular and cellular biochemistry · 2012Article
- Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.Molecular and cellular biochemistry · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer is a leading cause of cancer death worldwide. Complete resection offers the only chance for permanent control, and accurate staging and evaluation of treatment response are crucial for appropriate management. Positron Emission Tomography (PET) is increasingly used to complement anatomic imaging in cancer management. PET use in gastric cancer has been limited by 1) some gastric histologies are not PET avid, 2) spatial resolution limits the ability to distinguish between primary tumor and compartment I or II lymph nodes, and 3) the lack of a unified criteria in how to interpret PET for management decisions. New criteria have been proposed establishing response metrics in the utilization of PET. More study is needed to support these criteria in routine practice and establish the place of PET in the staging and management of gastric cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.